PPIB and Miyoshi myopathy: Sinopulmonary bacterial infections were reported in 15.7% (54, 59, 66), 8.5% (68, 91), and 7.8% (110, 113, 115, 122, 124, 127, 128, 134) of patients with CLL, MM, and NHL, respectively, when treated with B-lineage monoclonal antibodies as monotherapy (Table 6).